Objective
Myotonic dystrophy (DM) is a complex, autosomal dominant, multisystemic disease, with an unusual pathogenic mechanism. A growing body of evidence supports a trans-dominant pathological effect of toxic RNA transcripts containing expanded CUG repeats in DM t ype 1 (DM1), and CCUG repeats in DM type 2 (DM2). Involvement of the central nervous system (CNS) in DM has been widely reported, with variable degrees of mental dysfunction particularly associated with DM1. However, it is not understood whether RNA-mediat ed disease pathways are responsible for the brain-specific disease manifestations. In order to investigate the DNA dynamics and the molecular pathology underlying this condition, transgenic mouse models carrying long CTG repeat tracts were generated. These animals not only recreate disease-associated DNA instability, but also DM1 muscle and brain abnormalities. By uniquely exhibiting a brain phenotype, this model provides a distinctive and powerful tool to investigate the far-reaching molecular, physiologic al and phenotypic consequences of the trans-acting pathogenic DM1 repeat expansion in the CNS. Imaging, histological, proteomic and electrophysiological techniques will be combined in a multidisciplinary project to functionally characterise DM1 mental dysf unction, and to identify target genes affected by the toxic repeat. The data will reveal alterations at the molecular and cellular level, as well as at the higher hierarchical level of the brain network, providing important insight into the molecular neuro pathogenesis of this disease. Findings will contribute to the dissection of fundamental neuronal pathways, with predicted implications to the understanding of disease- and ageing-associated neurodegeneration, promoting the advance of this complex and fasci nating area of research within the European Community. In the long-term, the results emerging from this study will establish a solid basis for the rational design of therapeutic interventions.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences neurobiology
- medical and health sciences basic medicine neurology muscular dystrophies
- natural sciences biological sciences genetics DNA
- medical and health sciences basic medicine pathology
- natural sciences biological sciences genetics RNA
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP6-2002-MOBILITY-5
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
PARIS
France
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.